us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Gilead profits rise to €631m driven by 9% jump in turnover - Irish Examiner
Gilead profits rise to €631m driven by 9% jump in turnover Irish Examiner
📢 Published on 📅 5 December 2025 🕒 1:29 pm
Marshall Wace LLP Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Marshall Wace LLP Grows Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 5 December 2025 🕒 12:54 pm
Epoch Investment Partners Inc. Has $95.16 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Epoch Investment Partners Inc. Has $95.16 Million Stake in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 5 December 2025 🕒 9:56 am
Sprint Bioscience (Q3 review) - Gilead deal a strong confirmation - marketscreener.com
Sprint Bioscience (Q3 review) - Gilead deal a strong confirmation marketscreener.com
📢 Published on 📅 5 December 2025 🕒 7:58 am
Redeye: Sprint Bioscience (Q3 review) - Gilead deal a strong confirmation - TradingView
Redeye: Sprint Bioscience (Q3 review) - Gilead deal a strong confirmation TradingView
📢 Published on 📅 5 December 2025 🕒 7:58 am
Gilead's Seat at the Table of Conversations Centered Around HIV - Gilead Sciences
Gilead's Seat at the Table of Conversations Centered Around HIV Gilead Sciences
📢 Published on 📅 5 December 2025 🕒 12:05 am
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know Yahoo Finance
📢 Published on 📅 4 December 2025 🕒 2:00 pm
VestGen Advisors LLC Lowers Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
VestGen Advisors LLC Lowers Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 4 December 2025 🕒 1:25 pm
Channing Capital Management LLC Purchases 43,875 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Channing Capital Management LLC Purchases 43,875 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 4 December 2025 🕒 10:14 am
Gilead Township Board rejects proposed marijuana grow operation - WTVB
Gilead Township Board rejects proposed marijuana grow operation WTVB
📢 Published on 📅 4 December 2025 🕒 9:33 am
Indiana border township rejects marijuana operation - Coldwater Daily Reporter
Indiana border township rejects marijuana operation Coldwater Daily Reporter
📢 Published on 📅 4 December 2025 🕒 9:04 am
Invesco Ltd. Buys 3,394,330 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Invesco Ltd. Buys 3,394,330 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 3 December 2025 🕒 10:13 am
Transcript : Gilead Sciences, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11 - marketscreener.com
Transcript : Gilead Sciences, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11 marketscreener.com
📢 Published on 📅 2 December 2025 🕒 10:05 pm
Online Video Library | JW.ORG Videos English - JW.ORG
Online Video Library | JW.ORG Videos English JW.ORG
📢 Published on 📅 2 December 2025 🕒 6:28 pm
Online Video Library | JW.ORG Videos English - JW.ORG
Online Video Library | JW.ORG Videos English JW.ORG
📢 Published on 📅 2 December 2025 🕒 6:28 pm
Insider Activity Update: Jeffrey Bluestone Executes Options Exercise, Resulting In $296K At Gilead Sciences - Benzinga
📢 Published on 📅 2 December 2025 🕒 3:01 pm
2,222 Shares in Gilead Sciences, Inc. $GILD Purchased by Valued Retirements Inc. - MarketBeat
2,222 Shares in Gilead Sciences, Inc. $GILD Purchased by Valued Retirements Inc. MarketBeat
📢 Published on 📅 2 December 2025 🕒 1:23 pm
Prossimo Advisors LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Prossimo Advisors LLC Makes New Investment in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 2 December 2025 🕒 12:07 pm
JW Broadcasting—December 2025: 158th Gilead Graduation - JW.ORG
JW Broadcasting—December 2025: 158th Gilead Graduation JW.ORG
📢 Published on 📅 1 December 2025 🕒 7:28 pm
News Is Out hosting Gilead’s Choose U World AIDS Day panel - Dallas Voice
News Is Out hosting Gilead’s Choose U World AIDS Day panel Dallas Voice
📢 Published on 📅 1 December 2025 🕒 7:25 pm
Gifford Fong Associates Sells 25,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gifford Fong Associates Sells 25,000 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 1 December 2025 🕒 9:49 am
West Family Investments Inc. Has $1.35 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
West Family Investments Inc. Has $1.35 Million Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 30 November 2025 🕒 1:46 pm
Schroder Investment Management Group Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Schroder Investment Management Group Trims Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 30 November 2025 🕒 12:36 pm
What Gilead Sciences (GILD)'s First Lenacapavir Shipments in Africa Mean For Shareholders - simplywall.st
What Gilead Sciences (GILD)'s First Lenacapavir Shipments in Africa Mean For Shareholders simplywall.st
📢 Published on 📅 30 November 2025 🕒 12:56 am
Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline - Yahoo Finance
Gilead Sciences (GILD) Stock Outlook: Mizuho Lifts Target Amid Stronger Biktarvy Timeline Yahoo Finance
📢 Published on 📅 29 November 2025 🕒 6:09 pm
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? - Yahoo Finance
Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? Yahoo Finance
📢 Published on 📅 28 November 2025 🕒 1:35 pm
The Escalator: Gilead Sciences, Medtronic, Labcorp and more - Medical Marketing and Media
The Escalator: Gilead Sciences, Medtronic, Labcorp and more Medical Marketing and Media
📢 Published on 📅 26 November 2025 🕒 8:00 am
Gilead scoops up a preclinical cancer program - BioPharma Dive
Gilead scoops up a preclinical cancer program BioPharma Dive
📢 Published on 📅 25 November 2025 🕒 8:00 am
Gilead hatches $400M biobucks deal for Sprint’s TREX1 program - Fierce Biotech
Gilead hatches $400M biobucks deal for Sprint’s TREX1 program Fierce Biotech
📢 Published on 📅 24 November 2025 🕒 8:00 am
First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharan Africa – and What it Means for Ending the HIV Epidemic - Gilead Sciences
First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharan Africa – and What it Means for Ending the HIV Epidemic Gilead Sciences
📢 Published on 📅 21 November 2025 🕒 8:00 am
Gilead abruptly parts ways with general counsel—Chutes & Ladders - Fierce Biotech
Gilead abruptly parts ways with general counsel—Chutes & Ladders Fierce Biotech
📢 Published on 📅 21 November 2025 🕒 8:00 am
Gilead Sciences (GILD): Taking Stock of Valuation as Shares Approach Analyst Targets - Yahoo Finance
Gilead Sciences (GILD): Taking Stock of Valuation as Shares Approach Analyst Targets Yahoo Finance
📢 Published on 📅 19 November 2025 🕒 8:00 am
Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial - Reuters
Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial Reuters
📢 Published on 📅 19 November 2025 🕒 8:00 am
Without Explanation, Gilead Sciences Parts Ways With GC It Wooed Aboard in 2022 - Law.com
Without Explanation, Gilead Sciences Parts Ways With GC It Wooed Aboard in 2022 Law.com
📢 Published on 📅 19 November 2025 🕒 8:00 am
'Gilead wants us to rebuild': Why Galapagos isn't allowed to go extinct after turbulent year - Fierce Biotech
'Gilead wants us to rebuild': Why Galapagos isn't allowed to go extinct after turbulent year Fierce Biotech
📢 Published on 📅 19 November 2025 🕒 8:00 am
Gilead Sciences announces departure of executive vice president and general counsel - Investing.com
Gilead Sciences announces departure of executive vice president and general counsel Investing.com
📢 Published on 📅 19 November 2025 🕒 8:00 am
Gilead joins partners for delivery of first shipments of breakthrough twice-yearly lenacapavir for HIV prevention to sub-Saharan Africa - European AIDS Treatment Group
Gilead joins partners for delivery of first shipments of breakthrough twice-yearly lenacapavir for HIV prevention to sub-Saharan Africa European AIDS Treatment Group
📢 Published on 📅 19 November 2025 🕒 1:45 am
Is It Too Late to Reassess Gilead After Recent Drug Trial Success? - simplywall.st
Is It Too Late to Reassess Gilead After Recent Drug Trial Success? simplywall.st
📢 Published on 📅 18 November 2025 🕒 2:45 am
Is Gilead’s Successful Phase 3 HIV Regimen Trial Shifting the Investment Case for GILD? - Yahoo Finance
Is Gilead’s Successful Phase 3 HIV Regimen Trial Shifting the Investment Case for GILD? Yahoo Finance
📢 Published on 📅 14 November 2025 🕒 8:00 am
Gilead Sciences, Inc. (GILD)’s Mixed Quarter Draws Divergent Analyst Views - Yahoo Finance
Gilead Sciences, Inc. (GILD)’s Mixed Quarter Draws Divergent Analyst Views Yahoo Finance
📢 Published on 📅 14 November 2025 🕒 8:00 am
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV-1 treatment meets primary endpoint in Phase 3 ARTISTRY-1 trial - European AIDS Treatment Group
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV-1 treatment meets primary endpoint in Phase 3 ARTISTRY-1 trial European AIDS Treatment Group
📢 Published on 📅 13 November 2025 🕒 8:00 am
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial - Yahoo Finance
📢 Published on 📅 13 November 2025 🕒 8:00 am
Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings - Fierce Pharma
Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings Fierce Pharma
📢 Published on 📅 13 November 2025 🕒 8:00 am
Assessing Gilead After 34% Rally and Recent Pharmaceutical Partnerships - Yahoo Finance
Assessing Gilead After 34% Rally and Recent Pharmaceutical Partnerships Yahoo Finance
📢 Published on 📅 12 November 2025 🕒 8:00 am
Gilead fails outside triple negative | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Gilead fails outside triple negative | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
📢 Published on 📅 11 November 2025 🕒 8:00 am
How Recent Developments Are Shaping the Gilead Sciences Investment Story - Yahoo Finance
How Recent Developments Are Shaping the Gilead Sciences Investment Story Yahoo Finance
📢 Published on 📅 8 November 2025 🕒 8:00 am
Gilead's Trodelvy stumbles in first-line breast cancer trial, adding to shaky clinical track record - Fierce Pharma
Gilead's Trodelvy stumbles in first-line breast cancer trial, adding to shaky clinical track record Fierce Pharma
📢 Published on 📅 7 November 2025 🕒 8:00 am
Gilead's breast cancer drug fails to meet main goal of late-stage study - Reuters
Gilead's breast cancer drug fails to meet main goal of late-stage study Reuters
📢 Published on 📅 7 November 2025 🕒 8:00 am
Neglected & Emerging Viruses and Pandemic Preparedness - Gilead Sciences
Neglected & Emerging Viruses and Pandemic Preparedness Gilead Sciences
📢 Published on 📅 7 November 2025 🕒 6:46 am
Gilead’s Research Scholars Program Supports New Investigations into Rare Liver Disease - Gilead Sciences
Gilead’s Research Scholars Program Supports New Investigations into Rare Liver Disease Gilead Sciences
📢 Published on 📅 5 November 2025 🕒 8:00 am
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir) - Yahoo Finance
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir) Yahoo Finance
📢 Published on 📅 31 October 2025 🕒 7:00 am
Gilead's long-acting PrEP Yeztugo takes off while cell therapy declines continue to haunt sales - Fierce Pharma
Gilead's long-acting PrEP Yeztugo takes off while cell therapy declines continue to haunt sales Fierce Pharma
📢 Published on 📅 31 October 2025 🕒 7:00 am
Gilead posts higher profit on demand for HIV drugs, but overall sales dip - Reuters
Gilead posts higher profit on demand for HIV drugs, but overall sales dip Reuters
📢 Published on 📅 30 October 2025 🕒 7:00 am
Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs - statnews.com
Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs statnews.com
📢 Published on 📅 21 October 2025 🕒 7:00 am
A Look at Gilead Sciences’s Valuation Following Breakthrough HIV and Cancer Clinical Trial Results - Yahoo Finance
A Look at Gilead Sciences’s Valuation Following Breakthrough HIV and Cancer Clinical Trial Results Yahoo Finance
📢 Published on 📅 17 October 2025 🕒 7:00 am
Gilead Foundation Launches STEM Careers Partnership with Boys & Girls Clubs of America - Boys & Girls Clubs of America
Gilead Foundation Launches STEM Careers Partnership with Boys & Girls Clubs of America Boys & Girls Clubs of America
📢 Published on 📅 16 October 2025 🕒 7:00 am
Gilead to present data on potential first weekly oral treatment for HIV - Clinical Trials Arena
Gilead to present data on potential first weekly oral treatment for HIV Clinical Trials Arena
📢 Published on 📅 15 October 2025 🕒 7:00 am
A Look Inside Gilead's Inflammation Pipeline - Gilead Sciences
A Look Inside Gilead's Inflammation Pipeline Gilead Sciences
📢 Published on 📅 9 October 2025 🕒 7:00 am
Gilead’s Lost Decade Is Over. It’s Time to Buy the Stock. - Barron's
Gilead’s Lost Decade Is Over. It’s Time to Buy the Stock. Barron's
📢 Published on 📅 2 October 2025 🕒 7:00 am
Gilead Oncology Grantee Provides Practical Support for Patients Undergoing Breast Cancer Treatment - Gilead Sciences
Gilead Oncology Grantee Provides Practical Support for Patients Undergoing Breast Cancer Treatment Gilead Sciences
📢 Published on 📅 1 October 2025 🕒 3:12 pm
Gilead pumps up virology pipeline with drug transporter deal - Fierce Biotech
Gilead pumps up virology pipeline with drug transporter deal Fierce Biotech
📢 Published on 📅 29 September 2025 🕒 7:00 am
Did Gilead's (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative? - Yahoo Finance
Did Gilead's (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative? Yahoo Finance
📢 Published on 📅 22 September 2025 🕒 7:00 am
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - California State Portal | CA.gov
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences California State Portal | CA.gov
📢 Published on 📅 15 September 2025 🕒 7:00 am
Here's How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock - Yahoo Finance
Here's How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock Yahoo Finance
📢 Published on 📅 12 September 2025 🕒 7:00 am
Gilead beats whistleblower lawsuit over hepatitis C drugs - Reuters
Gilead beats whistleblower lawsuit over hepatitis C drugs Reuters
📢 Published on 📅 12 September 2025 🕒 7:00 am
Gilead Sciences Commits to Veeva Vault CRM - Veeva
Gilead Sciences Commits to Veeva Vault CRM Veeva
📢 Published on 📅 10 September 2025 🕒 7:00 am
What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025 - Yahoo Finance
What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025 Yahoo Finance
📢 Published on 📅 9 September 2025 🕒 7:00 am
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest - AIDS Healthcare Foundation
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest AIDS Healthcare Foundation
📢 Published on 📅 9 September 2025 🕒 7:00 am
US plans to bring Gilead HIV drug to market in high-burden HIV countries - Reuters
US plans to bring Gilead HIV drug to market in high-burden HIV countries Reuters
📢 Published on 📅 4 September 2025 🕒 7:00 am
Gilead starts building manufacturing hub under $32 billion planned US investments - Reuters
Gilead starts building manufacturing hub under $32 billion planned US investments Reuters
📢 Published on 📅 3 September 2025 🕒 7:00 am
4 Questions on Gilead’s New Technical Development Center with Stacey Ma & Jamie Moore - Gilead Sciences
4 Questions on Gilead’s New Technical Development Center with Stacey Ma & Jamie Moore Gilead Sciences
📢 Published on 📅 3 September 2025 🕒 7:00 am
Gilead breaks ground on Foster City manufacturing hub as $32B US investment plan plays out - Fierce Pharma
Gilead breaks ground on Foster City manufacturing hub as $32B US investment plan plays out Fierce Pharma
📢 Published on 📅 3 September 2025 🕒 7:00 am
Gilead breaks ground on AI-enabled biopharma hub at Foster City headquarters - KRON4
Gilead breaks ground on AI-enabled biopharma hub at Foster City headquarters KRON4
📢 Published on 📅 3 September 2025 🕒 7:00 am
Gilead Sciences - Fierce Pharma
Gilead Sciences Fierce Pharma
📢 Published on 📅 2 September 2025 🕒 5:30 pm
Paving the Way for the Future Pipeline: Gilead Builds New State-of-the-Art Research Center - Gilead Sciences
Paving the Way for the Future Pipeline: Gilead Builds New State-of-the-Art Research Center Gilead Sciences
📢 Published on 📅 29 August 2025 🕒 7:00 am
EU approves Gilead's new injection for preventing HIV - Reuters
EU approves Gilead's new injection for preventing HIV Reuters
📢 Published on 📅 26 August 2025 🕒 7:00 am
Exclusive: CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists - Reuters
Exclusive: CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists Reuters
📢 Published on 📅 21 August 2025 🕒 7:00 am
Drawing Inspiration from Nature: Olivier Nolan-Stevaux’s Work in Oncology Research - Gilead Sciences
Drawing Inspiration from Nature: Olivier Nolan-Stevaux’s Work in Oncology Research Gilead Sciences
📢 Published on 📅 14 August 2025 🕒 7:00 am
Message from the General Manager - Gilead Sciences
Message from the General Manager Gilead Sciences
📢 Published on 📅 12 August 2025 🕒 4:54 pm
Gilead trims assets partnered with Novo Nordisk, Arcus from pipeline - FirstWord Pharma
Gilead trims assets partnered with Novo Nordisk, Arcus from pipeline FirstWord Pharma
📢 Published on 📅 8 August 2025 🕒 7:00 am
Gilead posts flat second quarter profit, ups full-year outlook on strong HIV sales - Reuters
Gilead posts flat second quarter profit, ups full-year outlook on strong HIV sales Reuters
📢 Published on 📅 7 August 2025 🕒 7:00 am
Attorney General Jeff Jackson Secures Over $200 Million from Gilead Sciences for Paying Kickbacks to Doctors - NCDOJ (.gov)
Attorney General Jeff Jackson Secures Over $200 Million from Gilead Sciences for Paying Kickbacks to Doctors NCDOJ (.gov)
📢 Published on 📅 24 July 2025 🕒 3:08 am
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme - OAG DC (.gov)
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme OAG DC (.gov)
📢 Published on 📅 15 July 2025 🕒 7:00 am
Gilead Campaign Aims to Close HIV Gender Gap in UK - Gilead Sciences
Gilead Campaign Aims to Close HIV Gender Gap in UK Gilead Sciences
📢 Published on 📅 11 July 2025 🕒 7:00 am
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries - Reuters
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries Reuters
📢 Published on 📅 9 July 2025 🕒 7:00 am
Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access - MSF Access
📢 Published on 📅 3 July 2025 🕒 7:00 am
Gilead blames low RSV infection rates last season for scrapping 2 obeldesivir trials - Fierce Biotech
Gilead blames low RSV infection rates last season for scrapping 2 obeldesivir trials Fierce Biotech
📢 Published on 📅 27 June 2025 🕒 7:00 am
Gilead: 2025 TIME100 Most Influential Companies - Time Magazine
Gilead: 2025 TIME100 Most Influential Companies Time Magazine
📢 Published on 📅 26 June 2025 🕒 7:00 am
Building breakthroughs: Gilead invests in U.S. innovation - Axios
Building breakthroughs: Gilead invests in U.S. innovation Axios
📢 Published on 📅 25 June 2025 🕒 7:00 am
From the Margins - Gilead Sciences
From the Margins Gilead Sciences
📢 Published on 📅 24 June 2025 🕒 7:21 pm
‘Unseen Unheard: The untold breast cancer stories of Black women in the UK’ - Gilead Sciences
‘Unseen Unheard: The untold breast cancer stories of Black women in the UK’ Gilead Sciences
📢 Published on 📅 24 June 2025 🕒 7:21 pm
Looking Back to the Future: Gilead’s Long-Standing Commitment to Help End the HIV Epidemic - Gilead Sciences
Looking Back to the Future: Gilead’s Long-Standing Commitment to Help End the HIV Epidemic Gilead Sciences
📢 Published on 📅 20 June 2025 🕒 7:00 am
An Open Letter from Daniel O’Day, Chairman & CEO - Gilead Sciences
An Open Letter from Daniel O’Day, Chairman & CEO Gilead Sciences
📢 Published on 📅 18 June 2025 🕒 7:00 am
Investing in the U.S. - Gilead Sciences
Investing in the U.S. Gilead Sciences
📢 Published on 📅 9 June 2025 🕒 7:00 am
Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty - Reuters
Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty Reuters
📢 Published on 📅 30 May 2025 🕒 7:00 am
Gilead, bracing for tariffs, joins peers in US drug production push - BioPharma Dive
Gilead, bracing for tariffs, joins peers in US drug production push BioPharma Dive
📢 Published on 📅 8 May 2025 🕒 7:00 am
Bringing PBC Into Focus Through Art of Patient Stories - Gilead Sciences
Bringing PBC Into Focus Through Art of Patient Stories Gilead Sciences
📢 Published on 📅 7 May 2025 🕒 7:00 am
Message from the General Manager - Gilead Sciences
Message from the General Manager Gilead Sciences
📢 Published on 📅 15 April 2025 🕒 8:14 am
Advancing Oncology Care Through Gilead's Research Scholars Program - Gilead Sciences
Advancing Oncology Care Through Gilead's Research Scholars Program Gilead Sciences
📢 Published on 📅 5 March 2025 🕒 5:00 pm
Access Strategy for Long-Acting PrEP - Gilead Sciences
Access Strategy for Long-Acting PrEP Gilead Sciences
📢 Published on 📅 10 February 2025 🕒 3:03 pm
